Form 4 for DGX Quest Diagnostics
Accepted 2022-05-19 00:00:00 ET · period of report 2022-05-17 · accession 0001022079-22-000077 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-05-19 | 2022-05-17 | DGX | PREVOZNIK MICHAEL E | SVP, GC | M - OptEx | $66.51 | +50.6K | 89.8K | +129% | +$3.37M |
| D | 2022-05-19 | 2022-05-17 | DGX | PREVOZNIK MICHAEL E | SVP, GC | S - Sale+OE | $139.97 | -50.6K | 39.2K | -56% | -$7.08M |
| D | 2022-05-19 | 2022-05-17 | DGX | PREVOZNIK MICHAEL E | SVP, GC | M - OptEx | $66.51 | -50.6K | 0 | -100% | -$3.37M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-05-17 | M | A | 50,604 | $66.51 | 89,828 | D | — | — | |
| 2 | Common | Common Stock | 2022-05-17 | S | D | 50,604 | $139.97 | 39,224 | D | — | — | (F1) This transaction was executed in multiple trades at prices ranging from $139.56 to $140.51. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 3 | Derivative | Non-Qualifed Stock Option (right to buy) | 2022-05-17 | M | D | 50,604 | $66.51 | 0 | D | $66.51 · — to 2026-02-25 | 50,604 Common Stock | (F3) The options vested in three equal annual installments beginning with the first on February 25, 2017, the second on February 25, 2018 and the final on February 25, 2019. |